Chen Nahshon

519 total citations
23 papers, 247 citations indexed

About

Chen Nahshon is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Chen Nahshon has authored 23 papers receiving a total of 247 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Obstetrics and Gynecology, 9 papers in Reproductive Medicine and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Chen Nahshon's work include Ovarian cancer diagnosis and treatment (5 papers), BRCA gene mutations in cancer (4 papers) and Endometrial and Cervical Cancer Treatments (4 papers). Chen Nahshon is often cited by papers focused on Ovarian cancer diagnosis and treatment (5 papers), BRCA gene mutations in cancer (4 papers) and Endometrial and Cervical Cancer Treatments (4 papers). Chen Nahshon collaborates with scholars based in Israel, United States and Australia. Chen Nahshon's co-authors include Ofer Lavie, Arie Bitterman, Riad Haddad, Lena Sagi‐Dain, David Hazzan, Martha Dirnfeld, Zofnat Wiener‐Megnazi, Ido Feferkorn, Jacob Bornstein and Nadav Cohen and has published in prestigious journals such as American Journal of Obstetrics and Gynecology, Fertility and Sterility and Human Reproduction Update.

In The Last Decade

Chen Nahshon

19 papers receiving 244 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chen Nahshon Israel 8 98 78 76 75 60 23 247
Tatiana Michelon Brazil 12 96 1.0× 142 1.8× 82 1.1× 88 1.2× 37 0.6× 36 367
Vineet Mishra India 15 131 1.3× 63 0.8× 160 2.1× 155 2.1× 36 0.6× 82 522
Ali Ulvi Hakverdi Türkiye 11 85 0.9× 41 0.5× 99 1.3× 142 1.9× 21 0.3× 28 338
Sung Shin Shim South Korea 9 105 1.1× 36 0.5× 32 0.4× 41 0.5× 14 0.2× 22 283
İbrahim Ferhat Ürünsak Türkiye 13 181 1.8× 41 0.5× 61 0.8× 116 1.5× 12 0.2× 37 395
Radu Botezatu Romania 8 72 0.7× 28 0.4× 36 0.5× 69 0.9× 9 0.1× 67 223
Parikshit Tank India 7 127 1.3× 45 0.6× 130 1.7× 166 2.2× 12 0.2× 24 337
İlkkan Dünder Türkiye 12 68 0.7× 19 0.2× 157 2.1× 90 1.2× 53 0.9× 45 391
Anju Huria India 13 149 1.5× 26 0.3× 79 1.0× 157 2.1× 33 0.6× 46 432
Chamnan Tanprasertkul Thailand 10 96 1.0× 12 0.2× 48 0.6× 33 0.4× 22 0.4× 32 227

Countries citing papers authored by Chen Nahshon

Since Specialization
Citations

This map shows the geographic impact of Chen Nahshon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen Nahshon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen Nahshon more than expected).

Fields of papers citing papers by Chen Nahshon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chen Nahshon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen Nahshon. The network helps show where Chen Nahshon may publish in the future.

Co-authorship network of co-authors of Chen Nahshon

This figure shows the co-authorship network connecting the top 25 collaborators of Chen Nahshon. A scholar is included among the top collaborators of Chen Nahshon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chen Nahshon. Chen Nahshon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nahshon, Chen, et al.. (2025). Pathology results of risk‐reducing salpingo‐oophorectomy in BRCA1/2 carriers and long‐term clinical outcomes. International Journal of Gynecology & Obstetrics. 170(3). 1188–1198.
2.
Nahshon, Chen, et al.. (2024). The value of routine hemoglobin level evaluation following elective cesarean section: Is it worthwhile?. International Journal of Gynecology & Obstetrics. 168(1). 205–209.
3.
Nahshon, Chen, et al.. (2024). Surgical nodal assessment for endometrial hyperplasia - A meta-analysis and systematic review. Gynecologic Oncology. 188. 140–146. 1 indexed citations
4.
Nahshon, Chen, Mario M. Leitão, Ofer Lavie, & Yakir Segev. (2023). Effect of known pathological risk factors on the incidence of metastatic lymph nodes and survival in early‐stage vulvar cancer: SEER analysis. International Journal of Gynecology & Obstetrics. 164(1). 339–344. 1 indexed citations
5.
Nahshon, Chen, et al.. (2023). Sentinel lymph node sampling versus full lymphadenectomy in endometrial cancer: a SEER database analysis. International Journal of Gynecological Cancer. 33(10). 1557–1563. 3 indexed citations
6.
Nahshon, Chen, et al.. (2023). The effect of subsequent pregnancy and childbirth on stress urinary incontinence recurrence following midurethral sling procedure: a meta-analysis. American Journal of Obstetrics and Gynecology. 230(3). 308–314.e5. 1 indexed citations
7.
Nahshon, Chen, Ofer Lavie, & Galia Oron. (2023). Attitude of BRCA1/2 mutation carriers towards fertility preservation, family planning and preimplantation genetic testing for primary prevention of breast and ovarian cancer in the next generation. Journal of Assisted Reproduction and Genetics. 40(12). 2835–2842. 2 indexed citations
8.
Nahshon, Chen, et al.. (2023). Risk factors for pelvic organ prolapse recurrence following colpocleisis: A meta‐analysis. International Journal of Gynecology & Obstetrics. 164(3). 848–856. 4 indexed citations
9.
Nahshon, Chen, et al.. (2023). Attitude of BRCA1/2 mutation carriers towards surgical risk reduction for breast, ovarian and uterine cancer: still much to be done. International Journal of Gynecological Cancer. 34(2). 260–266.
11.
Nahshon, Chen, et al.. (2022). Breast Cancer Patients Are at Increased Risk of Developing Uterine Serous Cancer: Implications for Counseling – A SEER Analysis. Oncology Research and Treatment. 45(12). 728–735. 1 indexed citations
12.
Nahshon, Chen, et al.. (2022). Factors Affecting the Success of Repeated Misoprostol Course for the Treatment of Missed Abortion. Journal of Gynecology Obstetrics and Human Reproduction. 51(10). 102477–102477. 1 indexed citations
13.
Nahshon, Chen, et al.. (2022). Third trimester messenger RNA COVID-19 booster vaccination upsurge maternal and neonatal SARS-CoV-2 immunoglobulin G antibody levels at birth. European Journal of Obstetrics & Gynecology and Reproductive Biology. 274. 148–154. 7 indexed citations
14.
Nahshon, Chen, et al.. (2021). Comparison of day 2 and overnight day 3 frozen embryo transfers: A prospective randomized controlled trial. Reproductive Biology. 21(4). 100565–100565. 2 indexed citations
15.
Nahshon, Chen, Pninit Shaked‐Mishan, Nadav Cohen, et al.. (2021). The rapid SARS-CoV-2 antibody qualitative test is accurate for assessing immunity following vaccination during pregnancy. American Journal of Obstetrics and Gynecology. 226(1). S325–S325.
16.
Nahshon, Chen, Pninit Shaked‐Mishan, Nadav Cohen, et al.. (2021). Maternal and Neonatal SARS-CoV-2 Immunoglobulin G Antibody Levels at Delivery After Receipt of the BNT162b2 Messenger RNA COVID-19 Vaccine During the Second Trimester of Pregnancy. JAMA Pediatrics. 176(3). 290–290. 49 indexed citations
17.
Nahshon, Chen, Arie Bitterman, Riad Haddad, David Hazzan, & Ofer Lavie. (2020). Hazardous Postoperative Outcomes of Unexpected COVID‐19 Infected Patients: A Call for Global Consideration of Sampling all Asymptomatic Patients Before Surgical Treatment. World Journal of Surgery. 44(8). 2477–2481. 66 indexed citations
18.
Nahshon, Chen, et al.. (2020). Five-year survival decreases over time in patients with BRCA-mutated ovarian cancer: a systemic review and meta-analysis. International Journal of Gynecological Cancer. 32(1). 48–54. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026